E3 Ubiquitin Ligases as Immunotherapeutic Target in Atherosclerotic Cardiovascular Disease

Overview of attention for article published in Frontiers in Cardiovascular Medicine, June 2020

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 18 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 5,211 followers.

E3 Ubiquitin Ligases as Immunotherapeutic Target in Atherosclerotic Cardiovascular Disease. #lymphoma #lymsm https://t.co/v06OE4Hy2o

27 Jun 2020

Reply Repost Favourite

New Research: E3 Ubiquitin Ligases as Immunotherapeutic Target in Atherosclerotic Cardiovascular Disease: Chronic low-grade inflammation drives atherosclerosis and despite optimal pharmacological treatment of classical cardiovascular risk… https://t.co/ELW

05 Jun 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.